Abattis Bioceuticals Corp. (ATTBF)

[ebota12]

You know it wasn't $100m, it was $25m. That money is for an acquisition or two.

Dilution stinks but the hope is revenue from these two products help fund the third, those three fund the fourth, etc. so further dilution isn't necessary after a while.

I agree, this is only $10-$20k max revenue but at least it's a start.

I think another year or so this might be a decent stock.